We’re a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes. Our research leads us to believe that the new approach we’re taking could succeed in defeating herpes by inducing antibodies that mediate the killing of infected cells. We’re strongly committed to this fight, and so far our work has been supported with unprecedented data in multiple preclinical models.
Location: United States, Florida
Member count: 11-50
Total raised: $56M
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | Scientia V... | scientiavc... |
| - | Connectivi... | connectivi... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 23.07.2019 | Series A | $56M | - | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 23.07.2019 | X-Vax Tech... | X-Vax Technology, Inc., a Jupi... | USA | - | finsmes.co... |
| 23.07.2019 | X-Vax Tech... | X-Vax Technology, Inc. (X-VAX ... | - | - | citybizlis... |
| 23.07.2019 | X-Vax Tech... | - | - | - | jnjinnovat... |
| 23.07.2019 | X-Vax Tech... | JUPITER, FL, X-Vax Technolog... | - | - | vcnewsdail... |